Home › Vulvar Cancer
Vulvar Cancer clinical trials recruiting in the U.S.
17 studies for Vulvar Cancer are recruiting participants at sites across the United States.
Vulvar cancer is cancer of the labia or skin of a woman's genitals. It is very rare, but treatable. Having HPV is a risk factor. Get more details here.
Cities with the most studies
By state
- California3 studies
- Florida4 studies
- Maryland3 studies
- Massachusetts4 studies
- New Jersey3 studies
- Ohio4 studies
- Texas4 studies
Recently updated studies
Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT04169763E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT05639972E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT05686226A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
Recruiting
Ages 18 and older · Women · Updated Oct 16, 2026 · NCT07741968Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies
RecruitingPhase 2
Ages 18 and older · Women · Updated Oct 14, 2026 · NCT05979610DESTINY-PANTUMOUR04
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000Serial MRI Scans During Radiation Therapy
Recruiting
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT04188535Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
RecruitingPhase 2
Ages 18 and older · Women · Updated Aug 27, 2026 · NCT06492070A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT05592626Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
RecruitingPhase 1/2
Ages 18 to 99 · All sexes · Updated Jul 13, 2026 · NCT05000294Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
RecruitingPhase 2
Ages 50 and older · Women · Updated Apr 21, 2026 · NCT07407647Image-Guided Gynecologic Brachytherapy
Recruiting
Ages 18 to 100 · Women · Updated Dec 18, 2025 · NCT02993900Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
RecruitingPhase 2
Ages 18 and older · Women · Updated Nov 5, 2025 · NCT06677190NYSCF Scientific Discovery Biobank
RecruitingObservational study
30 Days · All sexes · Updated Mar 3, 2025 · NCT06203106Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 80 · Women · Updated Feb 28, 2025 · NCT00005095HPV Vaccine, Imiquimod, and Metformin Combination Trial
RecruitingPhase 2
Ages 18 to 64 · Women · Updated Nov 13, 2024 · NCT06686043Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
RecruitingPhase 2
Ages 18 and older · Women · Updated Aug 1, 2023 · NCT05076942From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.